title: Most breast cancer screening trials have a flawed design.
abstract: In the present article, we discuss that why most breast cancer screening trials have a flawed origin. We suggest some solutions to correct these flaws so that more valid and reliable screening trials can be conducted in the future.
authors.affiliation: Department of Surgery, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Nishant
authors.initials: N
authors.lastname: Gurnani
authors.forename: Anurag
authors.initials: A
authors.lastname: Srivastava